Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frank C Church

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Biomolecules|April 30, 2021
Treatment Options for Motor and Non-Motor Symptoms of Parkinson's DiseaseFrank C Church
Open Life Sciences|July 8, 2022
Suggestions on leading an academic research laboratory groupFrank C Church
Thrombosis Research|February 4, 2010
"Coagulation proteins with uncertain function"Frank C Church
Medical Hypotheses|February 9, 2020
Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's diseaseCarolyn J Reuland, Frank C Church
Journal of Oncology|December 2, 2011
Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator SystemJennifer C Carter, Frank C Church
Thrombosis Research|January 19, 2010
Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironmentMark W Gramling, Frank C Church
Experimental Cell Research|January 27, 2007
Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1Lea M Beaulieu, Frank C Church
Experimental and Molecular Pathology|March 27, 2012
Mature breast adipocytes promote breast cancer cell motilityJennifer C Carter, Frank C Church
Archives of Biochemistry and Biophysics|March 21, 2003
Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in bloodHaifeng M Wu, Frank C Church
PPAR Research|August 13, 2009
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Jennifer C Carter, Frank C Church
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Biomolecules|April 30, 2021
Treatment Options for Motor and Non-Motor Symptoms of Parkinson's DiseaseFrank C Church
Open Life Sciences|July 8, 2022
Suggestions on leading an academic research laboratory groupFrank C Church
Thrombosis Research|February 4, 2010
"Coagulation proteins with uncertain function"Frank C Church
Medical Hypotheses|February 9, 2020
Synergy between plasminogen activator inhibitor-1, α-synuclein, and neuroinflammation in Parkinson's diseaseCarolyn J Reuland, Frank C Church
Journal of Oncology|December 2, 2011
Peroxisome Proliferator-Activated Receptor-γ Ligands Alter Breast Cancer Cell Motility through Modulation of the Plasminogen Activator SystemJennifer C Carter, Frank C Church
Thrombosis Research|January 19, 2010
Plasminogen activator inhibitor-1 is an aggregate response factor with pleiotropic effects on cell signaling in vascular disease and the tumor microenvironmentMark W Gramling, Frank C Church
Experimental Cell Research|January 27, 2007
Activated protein C promotes breast cancer cell migration through interactions with EPCR and PAR-1Lea M Beaulieu, Frank C Church
Experimental and Molecular Pathology|March 27, 2012
Mature breast adipocytes promote breast cancer cell motilityJennifer C Carter, Frank C Church
Archives of Biochemistry and Biophysics|March 21, 2003
Arginine 25 and Arginine 28 of lactoferrin are critical for effective heparin neutralization in bloodHaifeng M Wu, Frank C Church
PPAR Research|August 13, 2009
Obesity and breast cancer: the roles of peroxisome proliferator-activated receptor-γ and plasminogen activator inhibitor-1Jennifer C Carter, Frank C Church
Pageof 5